Stryker (SYK) Shares Outstanding (2009 - 2026)
Stryker (SYK) posted quarterly Shares Outstanding (Entity) of $383.6 million for Q2 2026, little changed year-over-year from $382.3 million in Q2 2025, and little changed on a QoQ basis from $383.4 million in Q1 2026.
Stryker (SYK) Shares Outstanding (2009 - 2026) Analysis & Trends
Stryker has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $383.6 million in Q2 2026.
- Shares Outstanding (Entity) for Q2 2026 came in at $383.6 million, changed 0.33% year-over-year; the trailing twelve-month figure through Jun 2026 was $383.6 million (changed 0.33% YoY), and the FY2025 annual result was $382.5 million, changed 0.29% from the prior year.
- Shares Outstanding (Entity) was little changed at $383.6 million in Q2 2026, from $383.4 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $383.6 million in Q2 2026 and troughed at $378.2 million in Q1 2022.
- A 5-year average of $380.8 million and a median of $381.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest annual swing landed in 2023, when Shares Outstanding (Entity) increased 0.39%; it then climbed 0.29% in 2025.
- A 5-year view of Shares Outstanding (Entity) shows it stood at $378.7 million in 2022, then climbed by 0.37% to $380.1 million in 2023, then advanced by 0.34% to $381.4 million in 2024, then rose by 0.29% to $382.5 million in 2025, then climbed by 0.28% to $383.6 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $383.6 million in Q2 2026, $383.4 million in Q1 2026, and $382.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 192.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 383.50 Mn |
| Mar 31, 2026 | 382.90 Mn |
| Dec 31, 2025 | 382.20 Mn |
| Sep 30, 2025 | 382.40 Mn |
| Jun 30, 2025 | 382.20 Mn |
| Mar 31, 2025 | 381.70 Mn |
| Dec 31, 2024 | 381.00 Mn |
| Sep 30, 2024 | 381.10 Mn |
| Jun 30, 2024 | 381.00 Mn |
| Mar 31, 2024 | 380.40 Mn |
| Dec 31, 2023 | 379.60 Mn |
| Sep 30, 2023 | 379.80 Mn |
| Jun 30, 2023 | 379.70 Mn |
| Mar 31, 2023 | 379.00 Mn |
| Dec 31, 2022 | 378.20 Mn |
| Sep 30, 2022 | 378.40 Mn |
| Jun 30, 2022 | 378.30 Mn |
| Mar 31, 2022 | 377.70 Mn |
| Dec 31, 2021 | 377.00 Mn |
| Sep 30, 2021 | 377.10 Mn |